[go: up one dir, main page]

TN2009000068A1 - Salts of benzimidazolyl pyridyl ethers and formulations thereof - Google Patents

Salts of benzimidazolyl pyridyl ethers and formulations thereof

Info

Publication number
TN2009000068A1
TN2009000068A1 TN2009000068A TN2009000068A TN2009000068A1 TN 2009000068 A1 TN2009000068 A1 TN 2009000068A1 TN 2009000068 A TN2009000068 A TN 2009000068A TN 2009000068 A TN2009000068 A TN 2009000068A TN 2009000068 A1 TN2009000068 A1 TN 2009000068A1
Authority
TN
Tunisia
Prior art keywords
salts
formulations
pyridyl ethers
benzimidazolyl pyridyl
benzimidazolyl
Prior art date
Application number
TN2009000068A
Other languages
English (en)
Inventor
Piotr H Karpinski
Kangwen L Lin
Eric M Loeser
Augustus O Okhamafe
Paul Allen Sutton
Eduardo Sy
Rampurna Gullapalli
Ahmad Hashash
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2009000068A1 publication Critical patent/TN2009000068A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
TN2009000068A 2006-08-30 2009-02-27 Salts of benzimidazolyl pyridyl ethers and formulations thereof TN2009000068A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84117706P 2006-08-30 2006-08-30
US95446607P 2007-08-07 2007-08-07
PCT/US2007/019152 WO2008027523A2 (fr) 2006-08-30 2007-08-30 Sels d'éthers benzimidazolyle pyridyle et formulations associées

Publications (1)

Publication Number Publication Date
TN2009000068A1 true TN2009000068A1 (en) 2010-08-19

Family

ID=39027583

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2009000068A TN2009000068A1 (en) 2006-08-30 2009-02-27 Salts of benzimidazolyl pyridyl ethers and formulations thereof

Country Status (33)

Country Link
US (2) US8202998B2 (fr)
EP (1) EP2059518B1 (fr)
JP (1) JP5279712B2 (fr)
KR (1) KR20090043542A (fr)
CN (1) CN101516870B (fr)
AT (1) ATE504584T1 (fr)
AU (1) AU2007290388B2 (fr)
BR (1) BRPI0716243A2 (fr)
CA (1) CA2660376C (fr)
CL (1) CL2007002533A1 (fr)
CO (1) CO6150180A2 (fr)
CY (1) CY1112187T1 (fr)
DE (1) DE602007013774D1 (fr)
DK (1) DK2059518T3 (fr)
ES (1) ES2360968T3 (fr)
GT (1) GT200900045A (fr)
HR (1) HRP20110311T1 (fr)
IL (1) IL196811A (fr)
JO (1) JO2702B1 (fr)
MA (1) MA30711B1 (fr)
MX (1) MX2009002279A (fr)
MY (1) MY161829A (fr)
NO (1) NO20091236L (fr)
NZ (1) NZ574620A (fr)
PE (2) PE20080766A1 (fr)
PL (1) PL2059518T3 (fr)
PT (1) PT2059518E (fr)
RU (1) RU2457206C2 (fr)
SI (1) SI2059518T1 (fr)
TN (1) TN2009000068A1 (fr)
TW (1) TW200819438A (fr)
WO (1) WO2008027523A2 (fr)
ZA (1) ZA200900664B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20080766A1 (es) * 2006-08-30 2008-06-15 Novartis Ag Sales de benzimidazolil piridil eteres y formulaciones que las contienen
NZ579084A (en) 2007-03-02 2012-04-27 Novartis Ag Solid forms of { 1-methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl} -(4-trifluromethyl-phenyl)amine
CN102065859B (zh) * 2008-06-13 2012-10-03 诺瓦提斯公司 用于神经纤维瘤病的取代的苯并咪唑类
WO2010088335A1 (fr) * 2009-01-29 2010-08-05 Novartis Ag Benzimidazoles substitués destinés au traitement d'astrocytomes
WO2011044072A1 (fr) 2009-10-05 2011-04-14 Novartis Ag Combinaison de raf-265 et d'un activateur d'ampk destinée à être utilisée dans le traitement d'une maladie proliférative
RU2013130224A (ru) * 2010-12-03 2015-01-10 Новартис Аг Фармацевтические композиции
AU2020395495B2 (en) * 2019-12-02 2024-05-09 Astrazeneca Ab Solid pharmaceutical formulations of 6-(2-chloro-6-methylpyridin-4-yl)-5-(-4-fluorophenyl)-1,2,4-triazin-3-amine
CN114478519B (zh) * 2020-10-23 2024-06-11 励缔(杭州)医药科技有限公司 吡唑并吡啶类化合物或其盐及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299108B2 (en) * 2002-03-29 2012-10-30 Novartis Ag Substituted benzazoles and methods of their use as inhibitors of raf kinase
BR0308854A (pt) * 2002-03-29 2005-02-22 Chiron Corp Benzazolas substituìdas e seus usos como inibidoras de quinase raf
US20060189619A1 (en) 2005-02-24 2006-08-24 Wyeth 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds
PE20070335A1 (es) * 2005-08-30 2007-04-21 Novartis Ag Benzimidazoles sustituidos y metodos para su preparacion
US7731795B2 (en) 2005-12-02 2010-06-08 Clemson University Rhombohedral fluoroberyllium borate crystals and hydrothermal growth thereof for use in laser and non-linear optical applications and devices
DE602007005139D1 (de) * 2006-07-21 2010-04-15 Novartis Ag Formulierungen für benzimidazolylpyridylether
PE20080766A1 (es) 2006-08-30 2008-06-15 Novartis Ag Sales de benzimidazolil piridil eteres y formulaciones que las contienen

Also Published As

Publication number Publication date
US8202998B2 (en) 2012-06-19
HRP20110311T1 (hr) 2011-08-31
ATE504584T1 (de) 2011-04-15
AU2007290388A1 (en) 2008-03-06
CA2660376A1 (fr) 2008-03-06
CA2660376C (fr) 2014-04-15
CN101516870B (zh) 2013-09-11
JP2010502622A (ja) 2010-01-28
JO2702B1 (en) 2013-03-03
HK1131613A1 (en) 2010-01-29
DE602007013774D1 (de) 2011-05-19
IL196811A0 (en) 2009-11-18
PE20130814A1 (es) 2013-08-08
JP5279712B2 (ja) 2013-09-04
US8501785B2 (en) 2013-08-06
PT2059518E (pt) 2011-07-11
MA30711B1 (fr) 2009-09-01
CY1112187T1 (el) 2015-12-09
CN101516870A (zh) 2009-08-26
WO2008027523A2 (fr) 2008-03-06
ZA200900664B (en) 2009-12-30
US20120308651A1 (en) 2012-12-06
ES2360968T3 (es) 2011-06-10
MX2009002279A (es) 2009-03-20
NO20091236L (no) 2009-03-27
BRPI0716243A2 (pt) 2013-09-03
PL2059518T3 (pl) 2011-09-30
WO2008027523A3 (fr) 2008-04-10
CO6150180A2 (es) 2010-04-20
TW200819438A (en) 2008-05-01
MY161829A (en) 2017-05-15
RU2457206C2 (ru) 2012-07-27
RU2009111384A (ru) 2010-10-10
CL2007002533A1 (es) 2008-02-08
DK2059518T3 (da) 2011-05-16
US20100168060A1 (en) 2010-07-01
KR20090043542A (ko) 2009-05-06
PE20080766A1 (es) 2008-06-15
IL196811A (en) 2013-03-24
NZ574620A (en) 2011-05-27
AU2007290388B2 (en) 2011-07-14
EP2059518B1 (fr) 2011-04-06
EP2059518A2 (fr) 2009-05-20
SI2059518T1 (sl) 2011-06-30
GT200900045A (es) 2010-06-14

Similar Documents

Publication Publication Date Title
TN2009000068A1 (en) Salts of benzimidazolyl pyridyl ethers and formulations thereof
EA201071234A1 (ru) Производные изохинолинона в качестве nk3 антагонистов
WO2012077136A3 (fr) Procédé de préparation de dérivés de benzimidazole et de leurs sels
WO2009117676A3 (fr) Nouveaux dérivés de pipéridine servant d'inhibiteurs de stéaroyle-coa-désaturase
MY153985A (en) Aminotriazole derivatives as alx agonists
PH12013500773A1 (en) Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts
DE602008002934D1 (de) 2-cyclopropylthiazolderivate
MX2011008389A (es) Sal de tipo tosilato de un derivado de 5-pirazolil-2-piridona, util en el tratamiento de la enfermedad pulmonar obstructiva cronica (epoc).
UA99129C2 (ru) Производные оксадиазола и их применение в качестве потенциирующих средств рецепторов глутамата
MX2009003323A (es) Eteres de celulosa cuaternizados para productos para el cuidado personal.
MX2010008713A (es) Derivados de 5,6-bisaril-2-piridina-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de la urotensina ii.
EP2136639A4 (fr) Composés hétérocycliques fusionnés avec pyrid-2-yl, et leurs compositions et utilisations
EP2245029A1 (fr) Inhibiteurs hétérocycliques de la stéaroyl-coa désaturase
GEP20125649B (en) Benzimidazole compound crystal
WO2012001065A3 (fr) Méthode de prévention ou de traitement des tumeurs cutanées
BRPI0808172A2 (pt) Compostos heterocíclicos, composições compreendendo-os e métodos de seu uso.
MY183039A (en) Pyridin-2-yl derivatives as immunomodulating agents
UA101018C2 (ru) Пирролопиримидинкарбоксамиды
MX2010001938A (es) Metodos para preparar compuestos basados en 4-fenil-6-(2,2,2-trifl uoro-1-feniletoxi)pirimidina.
MX2012007385A (es) Derivados de aminoalquilpirimidina como anatagonistas del receptor h4 de histamina.
MX2010006253A (es) Proceso para la preparación de 5-(2-etil-dihidro-1h-inden-2-il)-1h -midazol y sales de los mismos.
IN2012DN00858A (fr)
WO2009081246A3 (fr) Diamines bicycliques en tant qu'agonistes de récepteur nicotinique
AR062591A1 (es) Sales de benzimidazolil piridil eteres y formulaciones que las contienen
WO2006099479A3 (fr) Methodes de traitement du cancer au moyen d'antagonistes de ppar-gamma